| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0099 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.0032 | 1 |